tiprankstipranks
Trending News
More News >
Oculis Holding (OCS)
NASDAQ:OCS

Compare Oculis Holding (OCS) vs. Competitors

Compare
177 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Oculis Holding
$22.03
$1.26B
-8.75
17.81%
6 Buy
0 Hold
0 Sell
Strong Buy
EyePoint Pharmaceuticals
$17.08
$1.41B
-5.71
87.49%
6 Buy
0 Hold
0 Sell
Strong Buy
Spyre Therapeutics
$30.14
$2.34B
-13.84
25.48%
7 Buy
0 Hold
0 Sell
Strong Buy
Praxis Precision Medicines
$294.38
$8.07B
-22.81
299.54%
14 Buy
0 Hold
1 Sell
Strong Buy
ARS Pharmaceuticals
$10.95
$1.08B
-13.51
-4.20%
4 Buy
0 Hold
0 Sell
Strong Buy
Upstream Bio, Inc.
$26.97
$1.49B
-12.06
70.11%
8 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
OCS
Oculis Holding
22.03
-0.35
-1.56%
EYPT
EyePoint Pharmaceuticals
17.08
9.33
120.39%
SYRE
Spyre Therapeutics
30.14
8.59
39.86%
PRAX
Praxis Precision Medicines
294.38
230.36
359.83%
SPRY
ARS Pharmaceuticals
10.95
-0.31
-2.75%
UPB
Upstream Bio, Inc.
27.54
16.11
140.94%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts